Calidi Biotherapeutics (CLDI) EPS (Basic) Growth (3y) (2025 - 2026)
Calidi Biotherapeutics (CLDI) EPS (Basic) Growth (3y) (2025 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.70 Bn | 131.85 Bn | 2.84 Bn | 6.85% |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.75 Bn | 3.93 Bn | 11.71% |
| 3 | Argenx Se | 65.36 Bn | 60.18 Bn | 1.37 Bn | 64.84% |
| 4 | Moderna | 59.15 Bn | 54.01 Bn | 52.00 Mn | 18.44% |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | 37.21% |
| 6 | Alnylam Pharmaceuticals | 31.88 Bn | 28.57 Bn | 992.69 Mn | 36.73% |
| 7 | BioNTech SE | 28.14 Bn | 9.75 Bn | 668.28 Mn | -26.87% |
| 8 | Insmed | 27.59 Bn | 26.43 Bn | 358.27 Mn | 67.51% |
| 9 | Royalty Pharma | 27.31 Bn | 26.48 Bn | - | -38.31% |
| 10 | Calidi Biotherapeutics | 1.96 Mn | -2.14 Mn | - | 91.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 91.10% |
| Dec 31, 2025 | -161.60% |
| Sep 30, 2025 | -314.45% |
| Jun 30, 2025 | -353.86% |
| Mar 31, 2025 | -563.10% |